Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raafat E F Fahim

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Review of Vaccines|March 19, 2013
Therapeutic vaccines against tobacco addictionRaafat E F Fahim, Paul D Kessler, Matthew W Kalnik
CNS & Neurological Disorders Drug Targets|January 11, 2012
Nicotine vaccinesRaafat E F Fahim, Paul D Kessler, Steven A Fuller, et al.
BMC Public Health|December 11, 2012
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trialPhilippe H J Hoogsteder, Daniel Kotz, Paul I van Spiegel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|March 19, 2013
Therapeutic vaccines against tobacco addictionRaafat E F Fahim, Paul D Kessler, Matthew W Kalnik
CNS & Neurological Disorders Drug Targets|January 11, 2012
Nicotine vaccinesRaafat E F Fahim, Paul D Kessler, Steven A Fuller, et al.
BMC Public Health|December 11, 2012
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trialPhilippe H J Hoogsteder, Daniel Kotz, Paul I van Spiegel, et al.
Pageof 1